Collaborating to Prevent Violence
Healthier Together Initiative awards $225,000 to community-based organizations delivering violence-prevention programs.
A Life-changing Therapy for a Devastating Disease
FDA approves first potentially curative gene therapy for the rare blood disorder beta thalassemia.
“It Doesn’t Kill to Ask”
CHOP joins national gun safety movement to address leading cause of death in kids.
A New Option for Children with Peanut Allergies
Study that builds on years of research at CHOP shows peanut patch is effective in young toddlers.
Building for the Future
CHOP joins forces with Gilbane/Pride/McKissack to create 350,000-square-foot pediatric research building.
A Very Special Milestone
CHOP celebrates 5,000 deliveries in Garbose Family Special Delivery Unit.
FDA Approves First Drug for Friedreich’s Ataxia
CHOP was a lead clinical site for the treatment.